secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Acquisition Corp./Cayman Islands (VACH)
CIK:        0002006815
Form:       8-K
Filed at:   2026-03-18T23:59:59+00:00
Accession:  0001829126-26-002460
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 5.07, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Acquisition shareholders approve Veraxa Biotech deal; 99.67% of Class A shares redeemed
--------------------------------------------------------------------------------

- Shareholders approved business combination with Veraxa Biotech AG at March 12, 2026 meeting.
- 25,217,315 Class A shares redeemed (~99.67%), leaving ~$885,556 in trust account.
- After closing, combined company to trade on Nasdaq as VRXA.
- Remaining 82,685 Class A shares will convert into Veraxa Biotech Holding AG shares.
- Closing subject to Nasdaq listing approvals and other customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006815/000182912626002460/0001829126-26-002460-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006815/000182912626002460/voyageracq_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-002460

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer